Evidence map›Paper›PMID 37793791›Full record

ArticleRNA (New York, N.Y.)2023

A highly efficient human cell-free translation system.

Nikolay A Aleksashin, Stacey Tsai-Lan Chang, Jamie H D Cate

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Overcoming the eIF2α Brake in Human Cell-Derived Translation Systems.bioRxiv : the preprint server for biology · 2025
    Article
  5. Review
  6. Review
  7. Review
  8. Optimizing Human Cell-Free System for Efficient Protein Production.Journal of microbiology and biotechnology · 2025
    Article
  9. BeyondChemical reviews · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. eIF3 engages with 3'-UTR termini of highly translated mRNAs.bioRxiv : the preprint server for biology · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. bioRxiv : the preprint server for biology · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Nikolay A AleksashinInnovative Genomics Institute, University of California-Berkeley, Berkeley, California 94720, USA.ORCID 0000-0002-3403-7587
Stacey Tsai-Lan ChangInnovative Genomics Institute, University of California-Berkeley, Berkeley, California 94720, USA.
Jamie H D CateInnovative Genomics Institute, University of California-Berkeley, Berkeley, California 94720, USA j-h-doudna-cate@berkeley.edu.ORCID 0000-0001-5965-7902
Innovative Genomics Institute · US

Funding

Selective Stalling of Human Translation by Small MoleculesR01GM131142 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI CATE, JAMIE H · 2019 to 2022
$1.2M
NIGMS NIH HHS R01 GM131142
6 · The paper itself

Abstract

Cell-free protein synthesis (CFPS) systems enable easy in vitro expression of proteins with many scientific, industrial, and therapeutic applications. Here we present an optimized, highly efficient human cell-free translation system that bypasses many limitations of currently used in vitro systems. This CFPS system is based on extracts from human HEK293T cells engineered to endogenously express GADD34 and K3L proteins, which suppress phosphorylation of translation initiation factor eIF2α. Overexpression of GADD34 and K3L proteins in human cells before cell lysate preparation significantly simplifies lysate preparation. We find that expression of the GADD34 and K3L accessory proteins before cell lysis maintains low levels of phosphorylation of eIF2α in the extracts. During in vitro translation reactions, eIF2α phosphorylation increases moderately in a GCN2-dependent fashion that can be inhibited by GCN2 kinase inhibitors. This new CFPS system should be useful for exploring human translation mechanisms in more physiological conditions outside the cell.

Indexed as

Eukaryotic Initiation Factor-2ProteinsCell-Free SystemHEK293 CellsHumansPhosphorylationProtein BiosynthesisEukaryotic Initiation Factor-2Proteinscell-free translation systemprotein synthesisribosome

Identifiers

PMID37793791
PMCPMC10653386
OpenAlexW4387330546

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.